MHC Class I Loss in Triple-negative Breast Cancer: A Potential Barrier to PD-1/PD-L1 Checkpoint Inhibitors. Dusenbery AC, Maniaci JL, Hillerson ND, Dill EA, et al. Am J Surg Pathol 2021 Jan 11. doi: 10.1097/PAS.0000000000001653.

Read + Share

Amedeo Smart

Independent Medical Education

Dusenbery AC, Maniaci JL, Hillerson ND, Dill EA, et al. MHC Class I Loss in Triple-negative Breast Cancer: A Potential Barrier to PD-1/PD-L1 Checkpoint Inhibitors. Am J Surg Pathol 2021 Jan 11. doi: 10.1097/PAS.0000000000001653.
PMID: 33739790